Avtor/Urednik		Ðorđević Betetto, Laura; Luzar, Boštjan; Pipan Tkalec, Živa; Ponorac, Svjetlana
Naslov		Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine
Tip		članek
Vol. in št.		Letnik 31, št. 2
Leto izdaje		2022
Obseg		str. 83-87
ISSN		1318-4458 - Acta dermatovenerologica Alpina, Panonnica et Adriatica
Jezik		eng
Abstrakt		Cutaneous vasculitis is a recognized and potentially serious adverse event of immunization with several vaccines, and COVID-19 vaccines are no exception. We present a case of cutaneous leukocytoclastic vasculitis occurring 17 days after inoculation with ad- enoviral vector vaccine (Ad26.COV2.S) in a previously healthy 30-year-old patient with no history of prior adverse events following vaccination. Transient laboratory abnormalities (mild proteinuria, cryoglobulinemia, and slightly diminished C3 complement level) were also noted, but they resolved with the resolution of skin changes after treatment with topical steroids. Although the frequen- cy of cutaneous vasculitis after COVID-19 vaccines is extremely low, it presents an important challenge for the clinician when faced with an uncertain and delicate decision whether these patients can safely receive booster doses of COVID-19 vaccine. Because vaccination certificates are necessary for day-to-day activities and have a limited validity date, this may be an uncomfortable issue.
Proste vsebinske oznake		kožni vaskulitis drobnih žil levkocitoklastični vaskulitis cepivo proti COVID-19 cutaneous small vessel vasculitis leukocytoclastic vasculitis COVID-19 vaccine